Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®

April 21, 2011 By Bio-Medicine.Org

IRVINGTON, N.Y., April 21, 2011 /PRNewswire/ — ORTHOCON, Inc.,
a privately-held therapeutic device company, today announced that
DEKRA and Health Canada have cleared its HEMASORB Absorbable
Bone Hemostat Matrix for clinical use and sale in Europe and
Canada.

HEMASORB is a ready-to-use, biocompatible, water
resistant, and absorbable putty designed to rapidly stop bleeding
when applied to damaged or cut bone. Control of bleeding from cut
bone is a problem in many operative procedures including spine,
orthopedic, cardiac, and craniomaxillofacial surgeries. Excessive
bleeding during surgery may impair the surgeon’s view of the
operative field, may result in the need for blood transfusions, and
may be associated with post-operative complications. ORTHOCON
estimates that over 3.5 million patients undergoing surgeries in
the United States, Europe, and Canada each year could benefit from
the intra-operative use of HEMASORB.

“We are pleased that HEMASORB has been cleared for
clinical use and sale in Europe and Canada,” said John J. Pacifico,
President and Chief Executive Officer of ORTHOCON. “We are
confident HEMASORB will provide surgeons in Europe and
Canada with an innovative and cost-effective tool to assist in
their management of intra-operative bone bleeding, and we fully
expect HEMASORB to become the standard of care for bone
hemostasis.”

HEMASORB, previously cleared by the Food and Drug
Administration (FDA) via the 510(k) premarket notification
process, was first introduced in the U.S. in 2010. The product has
been approved for sale at leading hospitals throughout the United
States and is used successfully by hundreds of surgeons. ORTHOCON
will continue to focus its efforts on increasing adoption of
HEMASORB in the U.S. and is actively pursuing product
distribution partnerships in Europe and Canada to ensure
HEMASORB becomes widely available to surgical patients in
these ma

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech